AJP - Heart AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 285: H1444-H1452, 2003. First published June 26, 2003; doi:10.1152/ajpheart.00306.2003
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/4/H1444    most recent
00306.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan-Albuquerque, N.
Right arrow Articles by Nemenoff, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplan-Albuquerque, N.
Right arrow Articles by Nemenoff, R. A.

Regulation of SM22{alpha} expression by arginine vasopressin and PDGF-BB in vascular smooth muscle cells

Nihal Kaplan-Albuquerque,1 Chrystelle Garat,1 Vicki Van Putten,1 and Raphael A. Nemenoff1,2

Departments of 1Medicine and 2Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

Submitted 3 April 2003 ; accepted in final form 16 June 2003

Vascular smooth muscle (SM) cells (VSMC) undergo phenotypic modulation in vivo and in vitro. This process involves coordinated changes in expression of multiple SM-specific genes. In cultured VSMC, arginine vasopressin (AVP) increases and PDGF decreases expression of SM {alpha}-actin (SMA), the earliest marker of SM cells (SMC). However, it is unknown whether these agents regulate other SM genes in a similar fashion. SM22{alpha} appears secondary to SMA during development and is also a marker for SMC. This study examined the regulation of SM22{alpha} expression by AVP and PDGF in cultured VSMC. Levels of SM22{alpha} mRNA and protein were increased by AVP and suppressed by PDGF. Consistent with these changes, AVP increased SM22{alpha} promoter activity, whereas PDGF inhibited basal promoter activity and blocked AVP-induced increase. Activation of both JNK and p38 MAPK pathways was necessary for AVP-mediated induction of SM22{alpha} promoter. Expression of constitutively active Ras produced similar suppressions on SM22{alpha} promoter activity as PDGF. Signaling relayed from PDGF/Ras activation involved Raf, or a protein that competes for this site, Ral-GDS, and phosphatidylinositol 3-kinase activation. Truncational analysis showed that the proximal location of three CArG boxes in the promoter was sufficient for AVP stimulation. Mutations in this CArG box reduced basal and AVP-stimulated promoter activity without effecting PDGF suppression. Overexpression of serum response factor enhanced basal and AVP-stimulated promoter activity but had no effect on PDGF-BB-induced suppression. These data indicate that AVP and PDGF initiate specific signaling pathways that control expression of multiple SM genes leading to phenotypic modulation.

signal transduction; transcriptional regulation; mitogen-activated protein kinase; stress response factor; CArG



Address for reprint requests and other correspondence: R. A. Nemenoff, Div. of Renal Diseases and Hypertension, Box C-281, Univ. of Colorado Health Sciences Center, 4200 E. Ninth Ave., Denver, CO 80262 (E-mail: Raphael.Nemenoff{at}UCHSC.edu).




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
J. Feng, M. A. Lawson, and P. Melamed
A Proteomic Comparison of Immature and Mature Mouse Gonadotrophs Reveals Novel Differentially Expressed Nuclear Proteins that Regulate Gonadotropin Gene Transcription and RNA Splicing
Biol Reprod, September 1, 2008; 79(3): 546 - 561.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Kaplan-Albuquerque, V. Van Putten, M. C. Weiser-Evans, and R. A. Nemenoff
Depletion of Serum Response Factor by RNA Interference Mimics the Mitogenic Effects of Platelet Derived Growth Factor-BB in Vascular Smooth Muscle Cells
Circ. Res., September 2, 2005; 97(5): 427 - 433.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Kaplan-Albuquerque, Y. E. Bogaert, V. Van Putten, M. C. Weiser-Evans, and R. A. Nemenoff
Patterns of Gene Expression Differentially Regulated by Platelet-derived Growth Factor and Hypertrophic Stimuli in Vascular Smooth Muscle Cells: MARKERS FOR PHENOTYPIC MODULATION AND RESPONSE TO INJURY
J. Biol. Chem., May 20, 2005; 280(20): 19966 - 19976.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.